ROMANIAN REGISTRY OF RHEUMATIC DISEASES: EFFICACY AND SAFETY OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS

被引：2
|
作者：
Codreanu, C. [1 ]
Mogosan, C. [1 ]
Enache, L. [1 ]
Stanciu, D. [1 ]
Ionescu, R. [2 ]
Opris, D. [2 ]
Rednic, S. [3 ]
Parvu, M. [4 ]
机构：
[1] Clin Ctr Rheumat Dis Dr I Stoia, Rheumatol, Bucharest, Romania
[2] Sfanta Maria Hosp, Rheumatol, Bucharest, Romania
[3] Cty Hosp, Rheumatol, Cluj Napoca, Romania
[4] Colentina Hosp, Rheumatol, Bucharest, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0107
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [21] Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
    Richa Mishra
    Vijay Singh
    Charles H. Pritchard
    Rheumatology International, 2011, 31 : 481 - 484
  • [22] Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
    Mishra, Richa
    Singh, Vijay
    Pritchard, Charles H.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (04) : 481 - 484
  • [23] The clinical efficacy of switching biologic therapy in rheumatoid arthritis: The gwent experience
    Martin, J.
    Groves, A.
    Attwood, L.
    Linton, S. M.
    RHEUMATOLOGY, 2006, 45 : I52 - I52
  • [24] Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis
    Lin, YT
    Tsai, MJ
    Wang, LH
    Huang, MT
    Yang, YH
    Chiang, BL
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (08) : 623 - 629
  • [25] Malignancy and biologic therapy in rheumatoid arthritis
    Askling, Johan
    Bongartz, Tim
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
  • [26] Rheumatoid arthritis and the era of biologic therapy
    Anshuman P. Malaviya
    Andrew J. K. Östör
    Inflammopharmacology, 2012, 20 (2) : 59 - 69
  • [27] Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations
    Horton, Sarah
    Buch, Maya H.
    Emery, Paul
    DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 101 - 119
  • [28] BIOLOGIC THERAPY RETENTION IN RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) ACCORDING TO THE MOSCOW ARTHRITIS REGISTRY (MAR)
    Lukina, G.
    Koltsova, E.
    Schmidt, E.
    Zhilyaev, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 848 - 848
  • [29] THE CLINICAL EFFICACY AND SAFETY OF ABATACEPT THERAPY IN BIOLOGIC NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS FROM JAPANESE MULTI-CENTER REGISTRY: 3-YEAR OUTCOMES
    Hanabayashi, M.
    Takahashi, N.
    Miyake, H.
    Yokota, Y.
    Kojima, T.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 727 - 728
  • [30] The safety of biologic agents in early rheumatoid arthritis
    Kavanaugh, A
    Keystone, EC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (05) : S203 - S208
12345